Bladder Cancer Flashcards

1
Q

What is the incidence of bladder cancer in the UK?

1 - 1.7 cases per 100,000
2 - 17 cases per 100,000
3 - 170 cases per 100,000
4 - 1700 cases per 100,000

A

2 - 17 cases per 100,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What age does the incidence of bladder cancer peak?

1 - >70
2 - >60
3 - >50
4 - >40

A

1 - >70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Is bladder cancer more common in men or women?

A
  • men

2.7:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following is NOT a typical risk factor for Transitional Cell Carcinoma of the Bladder and Ureters?

1 - Smoking 50%
2 - Petrochemicals
3 - Hairdressers (due to dye)
4 - Chronic bladder inflammation
5 - Schistosomiasis (parasitic worms)
6 - Alcohol
7 - Age

A

6 - Alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

All of the following are risk factors for bladder cancer, but which of the following is the biggest risk factor?

1 - Rubber manufacture
2 - Cyclophosphamide (medication used to treat myeloma)
3 - Smoking
4 - Petrochemicals
5 - Hairdressers (aniline dyes)
6 - Chronic bladder inflammation
7 - Schistosomiasis (parasitic worms) in Africa, Asia, S America, Caribbean
8 - Age

A

8 - Age

Closely followed by Smoking and Petrochemicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which 2 of the following countries has the highest incidence of bladder cancer?

1 - Uk
2 - Finland
3 - Egypt
4 - Spain
5 - Belgium

A

3 - Egypt
5 - Belgium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What cell type lines the inside of the bladder?

1 - transitional epithelium
2 - stratified columnar
3 - stratified cuboidal
4 - pseudocolumnar

A

1 - transitional epithelium
Called transitional as they change their shape and structure as the bladder stretches

There are 3 types of cell layers:

  • basal, intermediate, superficial
  • basal layer fosters the epithelial stem cells in order to provide constant renewal of the epithelium
  • most impermeable membrane in the body due to highly keratinized cellular membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

There are 3 main types of bladder cancer, which of these is most common, accounting for >90% of cases?

1 - Transitional Cell Carcinoma
2 - Squamous Cell Carcinoma
3 - Adenocarcinoma

A

1 - Transitional Cell Carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is Transitional Cell Carcinoma of the Bladder or Ureters more common?

A
  • bladder
  • accounts for 95% of all cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

There are 3 main types of bladder cancer, with Transitional Cell Carcinoma (TCC) (most common, Squamous Cell Carcinoma and Adenocarcinoma. Which of these typically has the best prognosis as they typically are superficial and do not move through the layers of the bladder?

1 - Transitional Cell Carcinoma
2 - Squamous Cell Carcinoma
3 - Adenocarcinoma

A

1 - Transitional Cell Carcinoma

Squamous Cell Carcinoma and Adenocarcinoma are more likely to:

  • have local invasion
  • higher grade
  • worse prognosis
  • more likely to have regional and distant lymph node metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transitional Cell Carcinoma of the bladder and ureter can be muscle invasive or non-invasive. Which is more common?

A
  • non-invasive muscle accounts for 80%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If a patient presents with haematuria, should we always consider Transitional Cell Carcinoma of the bladder and ureter?

A
  • always

Bladder cancer until proven otherwise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The following are all common signs of bladder cancer, but which is by far the most common?

1 - dysuria
2 - frequency
3 - haematuria
4 - urgency
5 - suprapubic pain.

A

3 - haematuria

Can be visible or microscopic

All of these symptoms are typically when the bladder cancer has progressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Haematuria is the most common symptom in bladder cancer. Is this painful or painless?

A
  • typically painless
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following is NOT a red flag sign in bladder cancer?

1 - haematuria
2 - weight loss
3 - fatigue
4 - thrombocytopenia
5 - anaemia.

A

4 - thrombocytopenia

Malignancy typically causes thrombocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

According to NICE guidelines if a patient presents to the GP with:

  • unexplained visible haematuria
  • without a UTI or persisting after treatment for a UTI, what age do they need to be to be referred on the 2 week wait?

1 - >35
2 - >45
3 - >55
4 - >65

A

2 - >45

17
Q

According to NICE guidelines if a patient presents to the GP with:

  • microscopic haematuria (not visible but positive on a urine dipstick)
  • dysuria (painful urinating) or;
  • raised WBC on a FBC

What age do they need to be for a 2 week referral?

1 - >30
2 - >40
3 - >50
4 - >60

A

4 - >60

18
Q

What is often the 1st line imaging in a patient with suspected Transitional Cell Carcinoma of the bladder and ureter?

1 - CT KUB
2 - ultrasound
3 - MRI-FDG
4 - chest-abdo and pelvic X-ray

A

2 - ultrasound

19
Q

Once an ultrasound has been performed, what is the imaging of choice to diagnose a patient with Transitional Cell Carcinoma of the bladder and ureter?

1 - CT KUB
2 - cystoscopy
3 - MRI-FDG
4 - chest-abdo and pelvic X-ray

A

2 - cystoscopy
- can also be used to take a biopsy and perform histology

20
Q

Which of the following is best for looking at local invasion spread of bladder cancer?

1 - ultrasound
2 - CT
3 - MRI
4 - CT-PET

A

3 - MRI

21
Q

CT-PET is used to stage Transitional Cell Carcinoma of the bladder and ureter. Which of the following stages does NOT come under the heading of non-invasive bladder cancer?

1 - T3 tumour invades perivescular tissue
2 - carcinoma in situ: cancer cells only affect the urothelium and are flat
3 - Ta: cancer only affecting the urothelium and projecting into the bladder
3 - T1: cancer invading the connective tissue layer beyond the urothelium, but not the muscle layer

A

1 - T3 tumour invades perivescular tissue

  • > T2 is muscle invasive bladder cancer and any lymph node and metastatic cancer
22
Q

Which of the following definitions is stage T1?

1 - tumour invades perivesicle tissue
2 - tumour invades surrounding tissue
3 - tumour is confined to the inner bladder (carcinoma in situ)
4 - tumour invades the muscle

A

3 - tumour is confined to the inner bladder (carcinoma in situ)

23
Q

Which of the following definitions is stage T2?

1 - tumour invades perivesicle tissue
2 - tumour invades surrounding tissue
3 - tumour is confined to the inner bladder (carcinoma in situ)
4 - tumour invades the muscle

A

4 - tumour invades the muscle

24
Q

Which of the following definitions is stage T3?

1 - tumour invades perivesicle tissue
2 - tumour invades surrounding tissue
3 - tumour is confined to the inner bladder (carcinoma in situ)
4 - tumour invades the muscle

A

1 - tumour invades perivesicle tissue

25
Q

Which of the following definitions is stage T4?

1 - tumour invades perivesicle tissue
2 - tumour invades surrounding organs
3 - tumour is confined to the inner bladder (carcinoma in situ)
4 - tumour invades the muscle

A

2 - tumour invades surrounding organs

26
Q

If a patient is diagnosed with Non-Muscle Invasive Transitional Cell Carcinoma (TCC) in the bladder and is low risk, how often are they monitored using cystoscopy?

1 - every 3 months only
2 - every 3 and 6 months
3 - every 3 and 12 months
4 - every 12 and 24 months

A

3 - every 3 and 12 months

27
Q

If a patient is diagnosed with Non-Muscle Invasive Transitional Cell Carcinoma (TCC) in the bladder and is intermediate risk, how often are they monitored using cystoscopy?

1 - every 3 months only
2 - every 3 and 6 months
3 - every 3 and 12 months
4 - every 12 and 24 months

A

2 - every 3 and 6 months
Continued for 3 years and then becomes annual and discharged after 5 years

Also given Intravesical mitomycin course x6

28
Q

If a patient is diagnosed with Non-Muscle Invasive Transitional Cell Carcinoma (TCC) in the bladder and is high risk, how often are they monitored using cystoscopy?

1 - every 3 months only
2 - every 3 and 6 months
3 - every 3 and 12 months
4 - every 12 and 24 months

A

1 - every 3 months only

Moves to every 6 months after 3 years

May also be given the TB vaccine, Bacillus Calmette–Guérin vaccine

This is a Tuberculosis vaccine that can be useful in patients who are at high risk of non-invasive muscle cancer returning

29
Q

What is the 1st line treatment of choice for non-invasive (T1 N0 M0) Transitional Cell Carcinoma of the bladder and ureter?

1 - Radical cystectomy
2 - Chemotherapy and
3 - Radiotherapy
4 - Cystoscopy and transurethral resection (TURBT)

A

4 - Cystoscopy and transurethral resection (TURBT)

TURBT = trans urethral resection of bladder tumour

Intravesical chemotherapy is typically given after TURBT

  • low risk = 3 and 12 months
  • med risk = 3, 6 and 12 months
  • high risk = every 3 months
30
Q

In patients who have had a Cystoscopy and transurethral resection (TURBT) procedure, what can they be given that causes inflammation and shedding of the epithelial cells of the bladder, including the tumour?

1 - Hepatitis B
2 - Bacillus Calmette–Guérin vaccine
3 - Epstein Barr virus
4 - Varicella-zoster virus

A

2 - Bacillus Calmette–Guérin vaccine

This is a Tuberculosis vaccine

Can be useful in patients who are at high risk of non-invasive muscle cancer returning

31
Q

In patients who have been confirmed as having muscle invasive bladder cancer, what imaging is used to stage the cancer?

1 - CT-KUB
2 - CT-CAP
3 - MRI with contrast
4 - cystoscopy

A

2 - CT-CAP
- CAP = chest, abdo and pelvis
- MRI, PET scan and bone scan can also be performed to look for metastasis

32
Q

In a patient with muscle invasive bladder carcinoma, there are a myriad of treatments available:

  • Neoadjuvant chemotherapy such as Gemcitabine and Cisplatin
  • Cystectomy (bladder removal) with an Ileal conduit or Neobladder
  • Radiotherapy

Metastatic Disease includes:
- Supportive care
- Chemotherapy
- Palliative (haemostatic) - radiotherapy

A

Neoadjuvant chemotherapy: Cisplatin-based combination chemotherapy is recommended before radical cystectomy for eligible patients.
Radical cystectomy: Complete surgical removal of the bladder, prostate or uterus, and regional lymph nodes. Urinary diversion options include ileal conduit, continent cutaneous reservoir, or orthotopic neobladder.
Bladder-sparing approaches: For select patients, a multimodal approach combining maximal TURBT, radiotherapy, and chemotherapy may be considered.
Adjuvant chemotherapy: May be considered for patients with high-risk features following cystectomy or bladder-sparing treatment.

33
Q

62 year old male who works as a mechanic presents to practice nurse with a potential UTI and painless haematuria for 2 weeks. He smokes and is urinating more often. Which of the following would be the best method to confirm a diagnosis?

1 - ultrasound
2 - MRI
3 - cystoscopy
4 - CT scan

A

3 - cystoscopy

Allows imaging and biopsy

34
Q

If a patient develops neutropenic sepsis due to the cancer treatment, in addition to initiating the sepsis 6, what can be given in an attempt to increase the neutrophil count?

1 -dexamethasone
2 - granulocyte colony stimulating factors (GCSF)
3 - blood transfusion
4 - frozen WBCs

A

2 - granulocyte colony stimulating factors (GCSF)